ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 43 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,000 | -90.0% | 10,500 | -67.7% | 0.00% | -100.0% |
| Q4 2022 | $390,000 | +89.3% | 32,500 | +1.5% | 0.00% | 0.0% |
| Q3 2022 | $206,000 | +160.8% | 32,004 | +88.3% | 0.00% | – |
| Q2 2022 | $79,000 | -34.7% | 17,000 | +21.4% | 0.00% | – |
| Q1 2022 | $121,000 | -39.2% | 14,000 | 0.0% | 0.00% | – |
| Q4 2021 | $199,000 | -67.7% | 14,000 | -50.0% | 0.00% | -100.0% |
| Q3 2021 | $616,000 | +58.4% | 28,000 | -3.4% | 0.00% | +100.0% |
| Q2 2021 | $389,000 | +60.1% | 29,000 | +20.8% | 0.00% | 0.0% |
| Q1 2021 | $243,000 | +326.3% | 24,000 | +77.8% | 0.00% | – |
| Q4 2020 | $57,000 | – | 13,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
| Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
| Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
| Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
| Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
| Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
| Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |